Body-Weight, Sex, and Hormones: Why Standard MDMA Dosing Guidance Does Not Fit Everyone Equally

Pharmacokinetic differences by body composition, biological sex, and hormonal state meaningfully affect MDMA plasma levels and duration, this piece explains the mechanisms and what they mean for dose adjustment in populations the standard weight-based tables underserve.

You did the math. You took your body weight, found a milligrams-per-kilogram figure in a dosing table, and landed on a number that felt responsible. But those tables were mostly built from a narrow slice of people, and your body may not process MDMA the way the average in that slice did. If you have ever felt markedly more hit than a friend of the same size on the same amount, the explanation is usually not in your head.

Why a weight-based number is only a starting point

The appeal of mg/kg dosing is obvious: it adjusts for the fact that a larger body dilutes a drug across more tissue and blood. That part is real. But it quietly assumes two things that are not true.

The first is that MDMA behaves in a straight line. It does not. MDMA shows nonlinear pharmacokinetics: it inhibits one of the main liver enzymes (CYP2D6) that clears it. So as the dose climbs, your body clears each additional milligram less efficiently. A dose only modestly higher can produce a disproportionately higher peak plasma level. This is well established and is one reason "just a bit more" is riskier than it sounds.

The second assumption is that bodies of the same weight are interchangeable. They are not. Two people at 70 kg can differ a lot in how much of that weight is fat versus lean tissue, in how their liver clears the drug, and in their hormonal environment on the day. Weight captures one variable and ignores several that matter.

Body composition, not just the number on the scale

MDMA is only moderately fat-soluble, and it distributes mostly into body water and lean tissue rather than parking in fat. This is the mechanistic catch with weight-based dosing.

• A person with a higher proportion of lean mass has a larger effective volume for the drug to spread into, which tends to lower peak concentration for a given dose.
• A person with more body fat at the same total weight has relatively less of that water-and-lean compartment, so the same milligrams can produce a higher concentration in the tissues that matter.

In plain terms: two people can weigh the same and get different plasma levels because the "same weight" is distributed differently. Scaling purely by total body weight can overshoot for someone whose weight is proportionally more fat. This is a mechanistic argument, not a precise correction factor, and nobody can give you a reliable personal multiplier from body composition alone.

Sex differences are real and not only about size

Once you account for body weight, is there still a sex difference? The evidence suggests yes, though it is mixed on magnitude.

Controlled studies have generally found that for a given weight-adjusted dose, women tend to reach somewhat higher MDMA plasma concentrations and report stronger subjective and physiological effects than men. Part of this tracks body composition, since women on average carry a higher fat fraction. But differences in enzyme activity and distribution appear to contribute beyond what weight and fat alone explain.

There is a specific and serious reason this matters. Hyponatremia - dangerously low blood sodium, driven by MDMA's effect on water retention combined with drinking too much water - has been reported disproportionately in women, and some cases have been severe. The interaction of hormones, fluid balance, and body water is the plausible mechanism. The practical consequence is in the callout below.

Where hormones come in

This is the genuinely under-covered part, and also where the evidence is thinnest, so grade it as emerging and partly inferred rather than settled.

Sex hormones influence the liver enzyme systems that metabolize MDMA, and they influence fluid and sodium balance directly. Estrogen in particular affects water retention and the hormonal signals that govern it. That gives a plausible biological route by which hormonal state - across the menstrual cycle, during pregnancy, or while taking hormonal contraception or hormone therapy - could shift both how much drug is circulating and how your body handles fluid.

What we can say honestly:

• The direction and size of any menstrual-cycle effect on MDMA specifically has not been well characterized in humans. Do not assume it mirrors what has been described for other substances.
• Hormonal contraceptives and hormone therapy alter the same enzyme and fluid-balance systems in principle, but there is no good human data quantifying how they change an MDMA dose. Treat it as unknown.
• The fluid-balance angle is the part worth taking seriously regardless, because hyponatremia is a concrete, documented harm.

What this means for the number you choose

None of this produces a tidy replacement formula. It produces humility about the one you were about to use.

• Treat weight-based tables as an upper-bound starting point, not a target, especially if you have a higher body-fat fraction or are female.
• Start lower than the table suggests and wait. MDMA takes time to come up; the nonlinear clearance means impatience is the risk.
• Factor in that your own response may differ from a similarly sized friend's for reasons you cannot see. Their dose is not evidence about yours.
• If you are pregnant, on hormone therapy, on medication affecting liver enzymes, or managing a health condition, the honest answer is that the data to guide you does not exist.

The lowest-risk option is always not to use at all. If you do, the mechanisms above all point the same way: smaller, slower, and no redosing is where the margin of safety actually lives.

Browse all articles →